The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is one of the best small-cap value stocks to buy. On April 20, ANI Pharmaceuticals, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the pricing of its offering of $275,000,000 aggregate principal amount ...
Delivered record quarterly adjusted non-GAAP EBITDA of $50.0 million, an increase of 65.7% year-over-year Diluted GAAP loss per share of $(0.55) and adjusted non-GAAP diluted earnings per share of ...
ANI announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate principal amount of convertible senior notes due 2029 in a private offering to persons reasonably ...
This included $59.4 million from Cortrophin Gel, up 42.3% YoY, and $27.6 million from newly acquired ophthalmology drugs ILUVIEN and YUTIQ. "We're thrilled to report another year of strong execution ...
StockStory.org on MSN
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q4, Stock Soars
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced in Q4 CY2024, with sales up 44.8% year on year ...
BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the fourth quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results